EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

m 6 A‐Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism

Juanyi Shi, Sintim Mui, Yongcong Yan, Shaomin Liu, Kai Wen, Chuanchao He, Huoming Li, Hao Liao, Meng Tao, Jiahua Wen, Weidong Wang, Xiaoding Xu und 2 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202503851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Juanyi Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Yat-Se…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Circular, RNA-Binding Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guangzhou, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) progression and therapy sensitivity are critically fueled by liver cancer stem cells (LCSCs), yet the regulatory mechanisms of circular RNAs (circRNAs) on LCSCs remain elusive. Here, through circRNA microarray analysis of LCSCs and non‐stem HCC cells, circRAPGEF1 is identified as a LCSC‐enriched circRNA upregulated in HCC tissues and predictive of poor patient survival. Functionally, circRAPGEF1 promoted the stemness properties, proliferation, and tumorigenicity of HCC cells. Mechanistically, the METTL3‐mediated N 6 ‐methyladenosine (m 6 A) modification of circRAPGEF1 facilitated KH domain‐dependent binding of IGF2BP3 to its UGGAC motif, which conferring stability to circRAPGEF1 while competitively disrupting the IGF2BP3/ ASS1 mRNA interaction. This process led to the degradation of ASS1 mRNA, triggering aspartate accumulation and activation of the S6K/CAD signaling pathway. Crucially, circRAPGEF1 overexpression reduced the sorafenib sensitivity, whereas targeting circRAPGEF1 using nanoparticles‐mediated systematic siRNAs delivery effectively sensitized HCC cells to sorafenib. Collectively, these findings unveil a METTL3/circRAPGEF1/IGF2BP3/ASS1 regulatory axis that drives aspartate metabolic reprogramming to fuel HCC stemness properties, positioning circRAPGEF1 as a dual prognostic biomarker and therapeutic target to enhance sorafenib efficacy in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRNA, CircularRNA-Binding ProteinsAspartic AcidHumansMiceDisease ProgressionAnimalsCell Line, TumorAdenosineNeoplastic Stem CellsGene Expression Regulation, NeoplasticMethyltransferasesCell Proliferation

Stichwörter der Autor:innen

aspartate metabolismcircular RNAshepatocellular carcinomaliver cancer stem cellsm6A modification

Substanzen

RNA, CircularRNA-Binding ProteinsIGF2BP3 protein, humanAspartic AcidAdenosineN-methyladenosineMethyltransferases

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
  • Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
  • Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
  • Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
  • Department of Interventional Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.

ORCID-Profile: Zhiyu Xiao

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Guangzhou
  • Guangdong Basic and Applied Basic Research Foundation
  • Beijing Xisike Clinical Oncology Research Foundation
  • Science and Technology Planning Project of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Shi, J., Mui, S., Yan, Y., Liu, S., Wen, K., He, C., Li, H., Liao, H., Tao, M., Wen, J., Wang, W., Xu, X., Zhou, Z., & Xiao, Z. (2025). m 6 A‐Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. Advanced Science. https://doi.org/10.1002/advs.202503851

Vancouver

Shi J, Mui S, Yan Y, Liu S, Wen K, He C, et al. m 6 A‐Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. Advanced Science. 2025. doi:10.1002/advs.202503851

BibTeX
@article{Shi2025,
  author = {Shi, Juanyi and Mui, Sintim and Yan, Yongcong and Liu, Shaomin and Wen, Kai and He, Chuanchao and Li, Huoming and Liao, Hao and Tao, Meng and Wen, Jiahua and Wang, Weidong and Xu, Xiaoding and Zhou, Zhenyu and Xiao, Zhiyu},
  title = {m 6 A‐Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202503851}
}
Kostenlos starten →